Based on feedback from the FDA, Aspire Biopharma plans on completing a multicenter clinical trial and then seeking regulatory approval for its new high-dose sublingual aspirin therapy. 

ASE President David Wiener, MD, discussed his goals for 2026 in a new video interview. "The imager who doesn't use artificial intelligence will be replaced by the imager who does,” he said.

Early evidence suggests CBD could help clinicians treat pericarditis, myocarditis and other significant heart conditions. Additional research is still required, however, including many more clinical trials.

With the deal, Envision will add a total of 42 freestanding centers across six states, ballooning its location count to more than 100 nationwide. 

The company is expanding into southwest Florida, one of the Sunshine State’s fastest growing geographies, with the purchase of Radiology Regional. 

Spring View Hospital, Lebanon, is teaming with RP effective Dec. 11, with the practice providing both on-site and remote radiology services. 

If you still think of large-language AI as a newish thing yet to catch on with healthcare consumers, think again.

Timesha Beauchamp, 20, suffered a seizure in August 2020 that required emergency medical attention. When responders arrived, they declared her dead at the scene. A short time later, she was found to be alive at a funeral parlor. More than five years later, a lawsuit stemming from the incident has been settled out of court. 

The extensions are used to supply patients with fluids and drugs through an IV line. Despite being labeled as having them, the devices do not contain an air-eliminating vent. Because there is a serious risk of air embolism associated with the error, the FDA has given this recall its most serious designation.

This news follows similar announcements from Humana, Cigna and UnitedHealthcare; a majority of insured Americans can now be treated with these technologies and have the procedure covered by their provider.